Hall N., Tokars R.P., O`Mara R.E.
P32 diphosphonate: a potential therapeutic agent
// J. Nucl. Med. 1975. V. 16. P. 532.
Han L.J., Au+Yong T.K., Tong W.C., Chu K.S., Szeto L.T., Wong C.P.
Comparison
of bone single photon emission tomography and planar imaging in the detection of verte
bral metastases in patients with back pain // Eur. J. Nucl. Med. 1998. V. 25(6).
P. 635 638.
Han S.H., Zonneberg B.A., de Klerk J.M., Quirijnen J.M., van het Schip A.D., van Dijk
A., Blijham G.H., van Rijk P.P.
186Re etidronate in breast cancer patients with metastatic
bone pain // J. Nucl. Med. 1999. V. 40(4) P. 639 642.
Hanks G.W., Hoskin P.J.
Opioid analgesics in the managment of the patients with
cancer // Palliative medicine. 1987. V.1. P.1 25.
Hansmann H.J., Wunsch C., Schneider B., Brado M., Flesch M., Richter G.M.,
Kauffmann G.W.
Radiologic diagnosis of bone metastases // Orthopade. 1998.
V. 27(4). P. 224 230.
Harrington K.D.
The use of methylmethacrylate as an adjunct in the internal fixation
of malignant neoplastic fractures // J. Bone Joint Surg. 1972. V. 54A. P. 1665
1676.
Harris A.L., Cantwell B.M.J., Carmichael J., Dawes P., Robinson A., Farndon J.,
Wilson R.
Phase II study of low dose aminogluthimide 250 mg/day plus hydrocortisone in
advanced postmenopausal breast cance // Eur. J. Cancer Oncol. 1989. V. 25.
P. 1105 1111.
Harvey H.A., Lipton A.
The role of bisphosphonates in the treatment of bone metas
tasesthe U.S. experience // Support Care Cancer. 1996. V. 4(3). P. 213 217.
Harvey H.A.
Issues concerning the role of chemotherapy and hormonal therapy of
bone metastases from breast carcinoma // Cancer. V. 80 (Suppl. 8). P. 1646 1651.
Hauenstein K.H., Vinee P., Adler C.P.
Percutaneous needle biopsy in skeletal metas
tases. Indications, technique, value and results // Radiologe. 1995. V. 35(1).
P. 39 46.
Hauschka P.V., Chen T.L., Mavrakos A.E.
Polypeptide growth factors in bone
matrix // Ciba Found. Symp. 1988. V. 136. P. 207 225.
Hauswirth A.E., Palmedo H., Dierke+Dzierzon C., Biersack H.J., Krebs D.
Pain ther
apy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP // Zentralbl.
Gynakol. V. 120(2). P. 83 86.
Hayes D.F., Van Zyl J.A., Hacking A.,
่ ๑๎เโ๒. Randomized comparison of tamox
ifen and two separate doses of toremifene in postmenopausal patients with metastatic
breast cancer // J. Clin. Oncol. 1995. V. 13. P. 2556 2566.
Hayward J.L., Carbbone P.P., Heuson J.C., Kumaoka S., Segaloff A., Rubens R.D.
Assessment of response to therapy in advanced breast cancer // Eur. J. Cancer Clin. Oncol.
1977. V. 13. P. 89 94.
Hemminki K.
DNA adducts, mutations, and cancer // Carcinogenesis. 1993.
V. 14 P. 2007 2012.
Hemminki K., Rajaniemi H., Lindahl B.,
่ ๑๎เโ๒. Tamoxifen induced DNA adducts
in endometrial samples from breast cancer patients // Cancer Res. 1996. V. 56.
P. 4374 4377.
Henderson J.C., Canellos G.P.
Cancer of the breast: the past decade // New Engl. J.
Med. 1980. V. 302. P.17 30.
Henderson J.E., Shustik C., Kremer R., Rabbani S.A., Hendy G.N., Goltzman D.
Immunoreactive parathyroid hormone like peptide in the plasma of patients with malig
229
ส๎๑๒ํ๛ๅ ์ๅ๒เ๑๒เ็๛ ๐เ๊เ ์๎๋๎๗ํ๎้ ๆๅ๋ๅ็๛
